Sign up to receive information from EYLEA and receive a free pocket magnifier. Sign up to receive information from EYLEA and receive a free pocket magnifier.

Sign Up

For the latest materials and communications about EYLEA, sign up today.

SIGN UP FOR MORE INFORMATION

Receive a free pocket magnifier when you sign up for access to the latest information about EYLEA.

Get the latest materials and communications about EYLEA—and a complimentary pocket magnifier, too.

This offer is valid while supplies last. All fields are required unless otherwise indicated.

Receive a free pocket magnifier when you sign up for access to the latest information about EYLEA.
I am a...
{{i.Text}}
Text
Please choose one
My loved one's diagnosis is...
{{d.Text}}
Please choose one
Are you currently being treated for your retinal eye disease?
Is your loved one currently being treated for their retinal eye disease?
{{c.Text}}
Please choose one
What are you being treated with?
What is your loved one being treated with?
{{opt.Text}}
Please choose one

First Name
Please enter your first name
Last Name
Please enter your last name
Email Address
Please enter a valid email address
Please enter a valid email address
Email isn't unique
Mobile Phone Number (Optional)
Please enter a valid phone number.
(ex: 888-888-8888)

Pocket magnifier shipping information (Optional):

Address
Please enter your address
Address 2 (Optional)
City
Please enter your city
State
{{item.FullName}}
Please enter your state
Please enter your state
ZIP Code
Please enter a valid ZIP code
Please enter a valid ZIP code
An error has occurred in the system, and the administrator of the application has been notified. Please try again later.
IMPORTANT SAFETY INFORMATION
  • EYLEA® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
  • Injection into the eye with EYLEA can result in an infection in the eye and retinal detachment (separation of retina from back of the eye). Inflammation in the eye has been reported with the use of EYLEA.
  • In some patients, injections with EYLEA may cause a temporary increase in eye pressure within 1 hour of the injection. Sustained increases in eye pressure have been reported with repeated injections, and your doctor may monitor this after each injection.
  • There is a potential risk of serious and sometimes fatal side effects related to blood clots, leading to heart attack or stroke in patients receiving EYLEA.
  • Serious side effects related to the injection procedure with EYLEA are rare but can occur including infection inside the eye and retinal detachment.
  • The most common side effects reported in patients receiving EYLEA are increased redness in the eye, eye pain, cataract, vitreous (gel-like substance) detachment, vitreous floaters, moving spots in the field of vision, and increased pressure in the eye.
  • It is important that you contact your doctor right away if you think you might be experiencing any side effects, including eye pain or redness, light sensitivity, or blurring of vision, after an injection.
  • EYLEA is for prescription use only. For additional safety information, please talk to your doctor and see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS

EYLEA® (aflibercept) Injection 2 mg (0.05mL) is a prescription medicine approved for the treatment of patients with Wet Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Please see the full Prescribing Information for EYLEA.

The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.

For U.S. Residents Only

EYLEA AND EYLEA4U are registered trademarks of Regeneron Pharmaceuticals, Inc.

© 2019, Regeneron Pharmaceuticals, Inc. All rights reserved.
777 Old Saw Mill River Road,
Tarrytown, NY 10591

05/2019
US-LEA-14281f(2) US-LEA-14281f(2)

 

Searching with Lea

Close
MENU